Integrating bispecific antibodies (bsAbs) for multiple myeloma (MM) into clinical practice requires coordinated efforts and comprehensive knowledge. In this on-demand video, expert faculty will guide hematology/oncology care teams, as well as internists/hospitalists, through practical strategies for coordinating bsAb referrals and transitions of care between academic and community centers for patients with relapsed/refractory MM. Learn how to integrate evidence-based bsAb therapies into your clinical practice, and understand key considerations for bsAb storage, preparation, administration, and monitoring by the hematology care team. Join us to enhance your approach to delivering cutting-edge care with bsAbs for your patients with MM.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/bispecific-antibodies-multiple-myeloma-innovative-multi-modal-accelerator-hub
- Start Date: 2024-08-21 05:00:00
- End Date: 2024-08-21 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Janssen (Any division) - Amount: 12500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest